Search - tctmd.com

Displaying 1 - 20 of 90

Sort: Relevancy | Date

News Conference News ACC 2026

Financial Support After Hospital Discharge Boosts HFrEF Outcomes: FUND-HF

L.A. McKeown

April 08, 2026

News Conference News ACC 2026

DIG-RHD: Digoxin Effective in Rheumatic Heart Disease

Michael O'Riordan

April 06, 2026

News Conference News ACC 2026

SCOUT-HCM: Mavacamten Can Benefit Teens With Obstructive HCM, Too

Caitlin E. Cox

March 30, 2026

Presentation ACC 2026

IVUS or angiography guidance for PCI in complex coronary bifurcation lesions: The DKCRUSH VIII Trial

Presenter: Shao-Liang Chen

March 30, 2026

News Conference News ACC 2026

SPIRIT-HF: Spironolactone’s Benefit Still Uncertain in HF With Preserved, Mildly Reduced EF

Todd Neale

March 29, 2026

Presentation ACC 2026

Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results From the Phase 2, Randomized, Placebo-Controlled CADENCE Study

Presenter: Mardi Gomberg-Maitland

March 29, 2026

Presentation ACC 2026

SPIRonolactone In the Treatment of Heart Failure

Presenter: Frank Edelmann

March 29, 2026

Presentation ACC 2026

Transcatheter Edge-to-Edge Repair for Severe Isolated Tricuspid Regurgitation

Presenter: Erwan Donal

March 29, 2026

Presentation ACC 2026

The STEMI Door to Unload Trial (STEMI-DTU)

Presenter: Gregg Stone

March 28, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

News Conference News ACC 2025

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

L.A. McKeown

April 03, 2025

News Conference News ACC 2025

Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP

Michael O'Riordan

April 01, 2025

News Conference News ACC 2025

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Michael O'Riordan

March 31, 2025

News Conference News ACC 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

Caitlin E. Cox

March 30, 2025

Presentation ACC 2025

The MIGHTy-Heart Randomized Clinical Trial

Presenter: Ruth Masterson Creber

March 30, 2025

Presentation ACC 2025

FAIR-HF2 Trial: Intravenous iron in patients with systolic heart failure and iron deficiency to improve morbidity & mortality

Presenter: Stefan D. Anker

March 30, 2025

Presentation ACC 2025

Liberal Fluid Intake versus Fluid Restriction in Chronic Heart Failure: The FRESH-UP Study

Presenter: Roland R. Van Kimmenade

March 30, 2025

Presentation ACC 2025

Dapagliflozin after Transcatheter Aortic Valve Implantation

Presenter: Sergio Raposeiras-Roubin

March 29, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Conference News ACC 2024

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

Caitlin E. Cox

April 15, 2024

Advertisement

Financial Support After Hospital Discharge Boosts HFrEF Outcomes: FUND-HF

DIG-RHD: Digoxin Effective in Rheumatic Heart Disease

SCOUT-HCM: Mavacamten Can Benefit Teens With Obstructive HCM, Too

IVUS or angiography guidance for PCI in complex coronary bifurcation lesions: The DKCRUSH VIII Trial

SPIRIT-HF: Spironolactone’s Benefit Still Uncertain in HF With Preserved, Mildly Reduced EF

Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results From the Phase 2, Randomized, Placebo-Controlled CADENCE Study

SPIRonolactone In the Treatment of Heart Failure

Transcatheter Edge-to-Edge Repair for Severe Isolated Tricuspid Regurgitation

The STEMI Door to Unload Trial (STEMI-DTU)

What’s Going to Be Hot at ACC 2026

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

The MIGHTy-Heart Randomized Clinical Trial

FAIR-HF2 Trial: Intravenous iron in patients with systolic heart failure and iron deficiency to improve morbidity & mortality

Liberal Fluid Intake versus Fluid Restriction in Chronic Heart Failure: The FRESH-UP Study

Dapagliflozin after Transcatheter Aortic Valve Implantation

What’s Going to Be Hot at ACC 2025?

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content